Literature DB >> 10638860

Cortical gray matter deficit in patients with bipolar disorder.

K O Lim1, M J Rosenbloom, W O Faustman, E V Sullivan, A Pfefferbaum.   

Abstract

BACKGROUND: cortical gray matter volume deficit and ventricular enlargement are well documented in schizophrenia, but their presence in bipolar disorder is less well established.
METHODS: global cortical gray matter, white matter and sulcal CSF, as well as lateral and third ventricular volume measures, were derived from axial MRI brain images obtained on age-matched bipolar (n=9), schizophrenic (n=9), and control (n=16) subjects. All subjects were free of history of alcohol or other substance dependence.
RESULTS: relative to controls, bipolar patients had widespread volume deficits of cortical gray matter but not of cortical white matter. Schizophrenic patients had an even more severe cortical gray matter deficit and greater sulcal and lateral ventricular enlargement than the bipolar patients.
CONCLUSIONS: this group of patients with bipolar disorder had a widespread deficit of cortical gray matter similar to, but less pronounced than, that observed in patients with schizophrenia.

Entities:  

Mesh:

Year:  1999        PMID: 10638860     DOI: 10.1016/s0920-9964(99)00063-8

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  15 in total

1.  Different gray matter patterns in chronic schizophrenia and chronic bipolar disorder patients identified using voxel-based morphometry.

Authors:  Vicente Molina; Gemma Galindo; Benjamín Cortés; Alba G Seco de Herrera; Ana Ledo; Javier Sanz; Carlos Montes; Juan A Hernández-Tamames
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-12-28       Impact factor: 5.270

2.  Brain enlargement and increased behavioral and cytokine reactivity in infant monkeys following acute prenatal endotoxemia.

Authors:  Auriel A Willette; Gabriele R Lubach; Rebecca C Knickmeyer; Sarah J Short; Martin Styner; John H Gilmore; Christopher L Coe
Journal:  Behav Brain Res       Date:  2010-12-27       Impact factor: 3.332

3.  Are Bipolar Disorder and Schizophrenia Neuroanatomically Distinct? An Anatomical Likelihood Meta-analysis.

Authors:  Kevin Yu; Charlton Cheung; Meikei Leung; Qi Li; Siew Chua; Gráinne McAlonan
Journal:  Front Hum Neurosci       Date:  2010-10-26       Impact factor: 3.169

Review 4.  [Changes in brain structure in bipolar affective disorders].

Authors:  H Scherk; W Reith; P Falkai
Journal:  Nervenarzt       Date:  2004-09       Impact factor: 1.214

5.  Diffusion tractography of the fornix in schizophrenia.

Authors:  J Fitzsimmons; M Kubicki; K Smith; G Bushell; R San Jose Estepar; C-F Westin; P G Nestor; M A Niznikiewicz; R Kikinis; R W McCarley; M E Shenton
Journal:  Schizophr Res       Date:  2008-11-30       Impact factor: 4.939

6.  Temporal lobe volume in bipolar disorder: relationship with diagnosis and antipsychotic medication use.

Authors:  Lindsay D Jones; Martha E Payne; Denise F Messer; John L Beyer; James R MacFall; K Ranga R Krishnan; Warren D Taylor
Journal:  J Affect Disord       Date:  2008-08-08       Impact factor: 4.839

7.  Brain's alpha activity is highly reduced in euthymic bipolar disorder patients.

Authors:  E Başar; B Güntekin; I Atagün; B Turp Gölbaşı; E Tülay; A Ozerdem
Journal:  Cogn Neurodyn       Date:  2011-09-01       Impact factor: 5.082

Review 8.  A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder.

Authors:  M L Phillips; C D Ladouceur; W C Drevets
Journal:  Mol Psychiatry       Date:  2008-06-24       Impact factor: 15.992

Review 9.  Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide.

Authors:  Jonathan Savitz; Wayne C Drevets
Journal:  Neurosci Biobehav Rev       Date:  2009-01-21       Impact factor: 8.989

10.  Schizophrenia and bipolar disorder are distinguished mainly by differences in neurodevelopment.

Authors:  Jenny Walker; Vivienne Curtis; Philip Shaw; Robin M. Murray
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.